Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Fampridine Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Purity:95%
  • 1.3.3 Purity:>95%
• 1.4 Market Segment by Application
  • 1.4.1 Global Fampridine Market Share by Application (2019-2025)
  • 1.4.2 Treatment of Multiple Sclerosis
  • 1.4.3 Potassium Channel Blocker
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Fampridine Production Value 2014-2025
  • 2.1.2 Global Fampridine Production 2014-2025
  • 2.1.3 Global Fampridine Capacity 2014-2025
  • 2.1.4 Global Fampridine Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Fampridine Market Size CAGR of Key Regions
  • 2.2.2 Global Fampridine Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Fampridine Capacity by Manufacturers
  • 3.1.2 Global Fampridine Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Fampridine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Fampridine Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Fampridine Market Concentration Ratio (CR5 and HHI)
• 3.3 Fampridine Price by Manufacturers
• 3.4 Key Manufacturers Fampridine Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Fampridine Market
• 3.6 Key Manufacturers Fampridine Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Purity:95% Production and Production Value (2014-2019)
  • 4.1.2 Purity:>95% Production and Production Value (2014-2019)
• 4.2 Global Fampridine Production Market Share by Type
• 4.3 Global Fampridine Production Value Market Share by Type
• 4.4 Fampridine Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Fampridine Consumption by Application

6 Production by Regions

• 6.1 Global Fampridine Production (History Data) by Regions 2014-2019
• 6.2 Global Fampridine Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Fampridine Production Growth Rate 2014-2019
  • 6.3.2 United States Fampridine Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Fampridine Import & Export
• 6.4 European Union
  • 6.4.1 European Union Fampridine Production Growth Rate 2014-2019
  • 6.4.2 European Union Fampridine Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Fampridine Import & Export
• 6.5 China
  • 6.5.1 China Fampridine Production Growth Rate 2014-2019
  • 6.5.2 China Fampridine Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Fampridine Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Fampridine Consumption by Regions

• 7.1 Global Fampridine Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Fampridine Consumption by Type
  • 7.2.2 United States Fampridine Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Fampridine Consumption by Type
  • 7.3.2 European Union Fampridine Consumption by Application
• 7.4 China
  • 7.4.1 China Fampridine Consumption by Type
  • 7.4.2 China Fampridine Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Fampridine Consumption by Type
  • 7.5.2 Rest of World Fampridine Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Tiefenbacher
  • 8.1.1 Tiefenbacher Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Fampridine
  • 8.1.4 Fampridine Product Introduction
  • 8.1.5 Tiefenbacher Recent Development
• 8.2 Clearsynth
  • 8.2.1 Clearsynth Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of Fampridine
  • 8.2.4 Fampridine Product Introduction
  • 8.2.5 Clearsynth Recent Development
• 8.3 Jubilant Pharma
  • 8.3.1 Jubilant Pharma Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of Fampridine
  • 8.3.4 Fampridine Product Introduction
  • 8.3.5 Jubilant Pharma Recent Development
• 8.4 Teva
  • 8.4.1 Teva Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of Fampridine
  • 8.4.4 Fampridine Product Introduction
  • 8.4.5 Teva Recent Development
• 8.5 Kunshan Zhendong Chemical
  • 8.5.1 Kunshan Zhendong Chemical Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of Fampridine
  • 8.5.4 Fampridine Product Introduction
  • 8.5.5 Kunshan Zhendong Chemical Recent Development
• 8.6 Yancheng Huahong Chemical
  • 8.6.1 Yancheng Huahong Chemical Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of Fampridine
  • 8.6.4 Fampridine Product Introduction
  • 8.6.5 Yancheng Huahong Chemical Recent Development

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Fampridine Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Fampridine Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Fampridine Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Fampridine Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Fampridine Production Forecast by Type
  • 9.7.2 Global Fampridine Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Fampridine Sales Channels
  • 10.2.2 Fampridine Distributors
• 10.3 Fampridine Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details

Fampridine are three isomers that are used as research tools to characterize potassium channel subtypes, as drugs for the treatment of some of the symptoms of multiple sclerosis, and on the surface for adults with some diseases. has improved.
In 2019, the market size of Fampridine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Fampridine.

This report studies the global market size of Fampridine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Fampridine production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Tiefenbacher
Clearsynth
Jubilant Pharma
Teva
Kunshan Zhendong Chemical
Yancheng Huahong Chemical
...

Market Segment by Product Type
Purity:95%
Purity:>95%

Market Segment by Application
Treatment of Multiple Sclerosis
Potassium Channel Blocker

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Fampridine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Fampridine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Fampridine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025